Embecta Corp.

EMBC Healthcare Medical Instruments & Supplies

Embecta Corp.’s revenue for fiscal 2025 (year ended September 2025) was $1.1 billion, down 3.80% from fiscal 2024. In the quarter to June 2026, revenue fell 8.05%, EPS fell 53.9%, free cash flow fell 49.6% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.27 0.18 −2.79%
Market cap
$365.5M
P/E
4.2×
Fwd P/E
3.8×
Dividend yield
5.10%
F-score
7/9
Altman Z
1.84
Beneish M
−3.11
Dividend safety
56/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 7 6 5
ROE
(13.74%) (20.19%) (16.43%) (13.65%)
ROA
8.03% 12.61% 10.41% 7.22%
ROIC
27.63% 32.36% 31.42% 21.44%
Return on Tangible Assets
15.21% 21.99% 18.70% 14.53%
Average Days of Receivables
49.19 53.82 51.50 65.28
Free Cash Flow per Share
3.13 3.67 3.62 2.99
Free Cash Flow
182.40 215.90 214.80 174.70
Other line items

Show all line items

Columns are period end dates